University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 14 of 23
FARE Peanut SLIT and Early Tolerance Induction
NCT02304991
ARC in Hemorrhagic Stroke
NCT02386202
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
NCT02312713
Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach
NCT02309099
PPV to Guide Fluid Management in the PICU
NCT02308371
Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients
NCT02215148
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
NCT02106910
Fabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study.
NCT02218541
Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults
NCT02236494
To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma
NCT02671643
Cochlear Implantation in Cases of Single-Sided Deafness
NCT02203305
Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults
NCT02218320
Impact of Graphic Cigarette Warnings
NCT02247908
Uniting Couples In the Treatment of Eating Disorders (UNITE)
NCT02419326
LNG-IUS at 2 Weeks Postpartum
NCT02121067
Brain Imaging of Intranasal Oxytocin Treatment in Autism
NCT01945957
Heart Healthy Lenoir: Return of Results Study
NCT02208180
Home Administration of FluMist by Parents/Caregivers
NCT01938170
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
NCT02226484
Sex and Female Empowerment
NCT02197715
Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis
NCT02228915
Mushroom Blend on Oxygen Kinetics
NCT02075892
Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers
NCT02183753
Nutrition for Migraine Prevention
NCT02012790
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919
Cohort Study of Risk Reducing Salpingectomy
NCT02165709
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
NCT02019745
A Pilot Study Evaluating Go NAP SACC's Web-based Nutrition Tool for Child Care
NCT02889198
Determining Relationships Among Maternity Stress & Sleep
NCT02133963
Trial of a Sugar-Sweetened Beverage Intervention in Overweight Mothers and Their Children Ages 3-5
NCT02098902
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
NCT01286350
Feasibility of Heart Rate Variability Biofeedback With In-patient Pregnant Women
NCT02119936
BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
NCT02068846
Choline Dehydrogenase and Sperm Function: Effects of Betaine
NCT02122211
Fatty Acids and Executive Function Development in 7-12 Year Olds
NCT02199808
Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients
NCT03057236
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
NCT02075905
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
NCT02094014
A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants
NCT02039323
The Effect of Rivaroxaban in Sickle Cell Disease
NCT02072668
Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise
NCT02076334
Phase I Study of Nicotinamide for Early Onset Preeclampsia
NCT02213094
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
NCT01963676
Improving Colon Cancer Screening for Diverse Populations
NCT02054598
Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes
NCT02033499
Efficacy and Safety of High Dose Baclofen for Alcohol Dependence
NCT01980706
Improving Diabetes Outcomes for Persons With Severe Mental Illness
NCT02053714
Oxytocin Levels in Typically Developing Boys
NCT02006381
Clinical Evaluation of Total-Etch and Self-Etch Dental Adhesives - 6 Year Recall
NCT02105896
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS)
NCT01998269
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.